UCSF study shows asthma self-management programs improve drug adherence, disease controlMay 07, 2009Asthma patients who spend as little as 30 minutes with a health care professional to develop a personalized self-management plan show improved adherence to medications and better disease control, according to a new study by a team of researchers at the University of California, San Francisco. Study findings are published in the April 2009 issue of "The Journal of Allergy and Clinical Immunology." May is National Asthma and Allergy Awareness Month. An estimated 20 million people in the United States have asthma and despite the availability of treatments, the disease remains poorly controlled among many individuals, according to the Asthma and Allergy Foundation of America. In 2007, the direct and indirect costs of asthma to the United States economy were $19.7 billion, reports the National Institute of Allergy and Infectious Diseases. "Mortality from asthma is preventable. However, many patients struggle to manage symptoms on their own and often end up visiting emergency departments. Our study indicates that in a clinical setting, personalized self-management education coupled with self-monitoring may be a cost-effective way to empower patients to better control their disease," said the study's lead author Susan L. Janson, DNSc, RN, NP, a UCSF clinical specialist in pulmonary disease. Earlier UCSF research has shown that teaching asthma patients how to self-manage their disease can improve health outcomes and that tailored education is more effective than standardized programs because patients find it more personally relevant. It has been unclear, however, which components of self-management education lead to better control of the disease, according to Janson, who also is a professor in the UCSF School of Nursing and adjunct professor in the UCSF School of Medicine. The UCSF team conducted a 24-week randomized, controlled trial to determine if individualized instruction in asthma self-management adds significantly to the effects of self-monitoring alone on patients' adherence to inhaled corticosteroids (ICSs), medications that can help reduce inflammation in the airway and prevent asthma attacks. In the study, 84 adults with asthma self-monitored their symptoms and kept a daily log of their peak expiratory air flow. Of that group, 45 patients were randomly selected to also receive a personal 30-minute session that included asthma information, personally relevant allergen exposure reduction, a personal action plan, and instruction in the correct use of their inhalers. According to Janson, many people with asthma don't receive the full advantage of inhalers because they don't breathe deeply enough or sometimes swallow the medication. In addition, different models of inhalers require different techniques to operate effectively. Members of the intervention group also were skin tested for allergies, and strategies were then developed to reduce allergens in their surroundings. "Environmental exposure is an important factor to evaluate when asthma is out of control," said Janson. "People understandably are reluctant to get rid of a pet or spend money on dust mite covers for their beds without knowing if animals or dust mites are aggravating the disease. A personalized approach helps patients develop skills specific to their own allergies." During the study period, adherence to ICSs was consistently higher in the intervention group compared with the control group. In addition, participants in the intervention group experienced fewer nighttime awakenings, a marker of asthma control. Intervention participants also used rescue inhalers less frequently, experienced an increased sense of control over their asthma, and had a significant decrease in their levels of tryptase, which is released from cells in the presence of allergens. Co-authors of the study are Kelly Wong McGrath, BA; Jack K. Covington, BA; Su-Chun Cheng, DSc; and Homer A. Boushey, MD, all from UCSF. The study was supported by a grant from the National Heart, Lung and Blood Institute, and donated, unrestricted funds from GlaxoSmithKline. UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, visit http://www.ucsf.edu. The University of California, San Francisco |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Women with asthma feel worse Women with asthma are more anxious, find it harder to sleep and are more tired during the day than their male counterparts, but nevertheless tend to be better at following their treatment. Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||